LGP
BIO icon

Leonard Green & Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Leonard Green & Partners’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-10,000
Closed -$4.51M – 29
2020
Q2 		$4.51M Buy
+10,000
New +$4.41M 0.84% 20

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Leonard Green & Partners's BIO Position: Q3 2020 in Review

Leonard Green & Partners sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2020, closing a stake of 10,000 shares — an estimated $4.51M sold.

Leonard Green & Partners first reported a position in BIO in Q2 2020 and held it in 1 quarter. The position peaked at $4.51M in Q2 2020. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Leonard Green & Partners reported no remaining Bio-Rad Laboratories Class A position as of Q3 2020 after selling out during the quarter.
  • Leonard Green & Partners sold 10,000 Bio-Rad Laboratories Class A shares in Q3 2020, an estimated $4.51M.
  • Leonard Green & Partners first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and held it in 1 quarter.
  • Leonard Green & Partners's Bio-Rad Laboratories Class A position peaked at $4.51M in Q2 2020.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Leonard Green & Partners's 13F filing for Q3 2020, filed 16 Nov 2020.